Axiom Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Axiom Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Buy	23,292 +21,905	+1,579%	+$1.26M	0.9%	33
2026 Q1	$84.1K	Buy	+1,387	New	+$80.9K	0.06%	159
2022 Q4	–	Sell	-86	Closed	-$6K	–	126
2022 Q3	$6K	Buy	+86	New	+$6.24K	0.01%	276
2022 Q1	–	Sell	-10,729	Closed	-$668K	–	99
2021 Q4	$668K	Sell	10,729 -9,248	-46%	-$542K	0.65%	37
2021 Q3	$1.18M	Buy	+19,977	New	+$1.32M	1.19%	20
2021 Q1	–	Sell	-434	Closed	-$214K	–	197
2020 Q4	$214K	Buy	+434	New	+$26.7K	0.19%	109
2019 Q4	–	Sell	-37,197	Closed	-$1.89M	–	148
2019 Q3	$1.89M	Sell	37,197 -102,803	-73%	-$4.83M	1.44%	16
2019 Q2	$6.36M	Sell	140,000 -518	-0.4%	-$24.1K	1.15%	17
2019 Q1	$6.73M	Buy	140,518 +2,001	+1%	+$99.7K	1.28%	14
2018 Q4	$7.2M	Buy	+138,517	New	+$7.44M	1.52%	13

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Axiom Investment Management's BMY Position: Q2 2026 in Review

Axiom Investment Management increased its Bristol-Myers Squibb (BMY) stake by 1,579% in Q2 2026, buying an estimated $1.26M and bringing the position to 23,292 shares worth $1.34M. The position accounts for 0.9% of the portfolio, ranked #33.

Axiom Investment Management first reported a position in BMY in Q4 2018 and has held it in 10 quarters since. The position peaked at $7.2M in Q4 2018. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Axiom Investment Management held 23,292 shares of Bristol-Myers Squibb worth $1.34M as of Q2 2026.
Axiom Investment Management bought 21,905 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.26M.
Bristol-Myers Squibb made up 0.9% of Axiom Investment Management's portfolio in Q2 2026, its #33 holding.
Axiom Investment Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 10 quarters since.
Axiom Investment Management's Bristol-Myers Squibb position peaked at $7.2M in Q4 2018.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.